Search Results - "Englesbe, M. J."

Centers for Disease Control ‘High‐Risk’ Donors and Kidney Utilization by Duan, K. I., Englesbe, M. J., Volk, M. L.

“…The aims of this study were to determine whether Centers for Disease Control high risk (CDCHR) status of organ donors affects kidney utilization and recipient…”
Get full text

Reducing Pediatric Liver Transplant Complications: A Potential Roadmap for Transplant Quality Improvement Initiatives Within North America by Englesbe, M. J., Kelly, B., Goss, J., Fecteau, A., Mitchell, J., Andrews, W., Krapohl, G., Magee, J. C., Mazariegos, G., Horslen, S., Bucuvalas, J.

“…Though robust clinical data are available within transplantation, these data are not used for broad‐based, multicentered quality improvement initiates. This…”
Get full text

The Riskiest Job in Medicine: Transplant Surgeons and Organ Procurement Travel by Englesbe, M. J., Merion, R. M.

“…Transplant surgeons are exposed to workplace risk due to the urgent nature of travel related to organ procurement. A retrospective cohort study was completed…”
Get full text

Recovery and Utilization of Deceased Donor Kidneys from Small Pediatric Donors by Pelletier, S. J., Guidinger, M. K., Merion, R. M., Englesbe, M. J., Wolfe, R. A., Magee, J. C., Sollinger, H. W.

“…The optimal use of kidneys from small pediatric deceased donors remains undetermined. Using data from the Scientific Registry of Transplant Recipients, 2886…”
Get full text

Case Mix, Quality and High‐Cost Kidney Transplant Patients by Englesbe, M. J., Dimick, J. B., Fan, Z., Baser, O., Birkmeyer, J. D.

“…A better understanding of high‐cost kidney transplant patients would be useful for informing value‐based purchasing strategies by payers. This retrospective…”
Get full text

Marijuana Use in Potential Liver Transplant Candidates by Ranney, D. N., Acker, W. B., Al‐Holou, S. N., Ehrlichman, L., Lee, D. S., Lewin, S. A., Nguyen, C., Peterson, S. F., Sell, K., Kubus, J., Reid, D., Englesbe, M. J.

“…Concern exists that liver transplant center substance abuse policies may have an inappropriate and disproportionate impact on marijuana users. Our hypothesis…”
Get full text

Young Transplant Surgeons and NIH Funding by Englesbe, M. J., Sung, R. S, Segev, D. L.

“…Transplant surgeons have historically been instrumental in advancing the science of transplantation. However, research in the current environment inevitably…”
Get full text

Risk Factors for Urinary Complications After Renal Transplantation by Englesbe, M. J., Dubay, D. A., Gillespie, B. W., Moyer, A. S., Pelletier, S. J., Sung, R. S., Magee, J. C., Punch, J. D., Campbell, D. A., Merion, R. M.

“…Urinary complications are common following renal transplantation. The aim of this study is to evaluate the risk factors associated with renal transplant…”
Get full text

The Effects of Donor and Recipient Practices on Transplant Center Finances by Englesbe, M. J., Ads, Y., Cohn, J. A., Sonnenday, C. J., Lynch, R., Sung, R. S., Pelletier, S. J., Birkmeyer, J. D., Punch, J. D.

“…Over the past several years we have noted a marked decrease in this profitability of our kidney transplant program. Our hypothesis is that this reduction in…”
Get full text

Time‐Trends in Publication Productivity of Young Transplant Surgeons in the United States by Englesbe, M. J., Lynch, R. J., Sung, R. S., Segev, D. L.

“…To further clarify whether the transplant surgical research workforce is adequately poised to further scientific achievement, we have investigated the…”
Get full text

Improving Organ Procurement Practices in Michigan by Lynch, R. J., Mathur, A. K., Hundley, J. C., Kubus, J., Pietroski, R. E., Mattice, B. J., Punch, J. D., Englesbe, M. J.

“…Travel to procure deceased donor organs is associated with risk to transplant personnel. In many instances, multiple teams are present for a given operation…”
Get full text

5 Years After Tragedy: An Update on Organ Procurement Travel in Michigan by Sheetz, K. H., Kanitz, W. J., Englesbe, M. J., Waits, S. A.

Get full text

Comparison of Histidine‐Tryptophan‐Ketoglutarate and University of Wisconsin Preservation in Renal Transplantation by Lynch, R. J., Kubus, J., Chenault, R. H., Pelletier, S. J., Campbell, D. A., Englesbe, M. J.

“…Histidine‐tryptophan‐ketoglutarate (HTK) is replacing University of Wisconsin (UW) solution as the preservation fluid for renal allografts in many centers, but…”
Get full text

A Call for a National Transplant Surgical Quality Improvement Program by Englesbe, M. J., Pelletier, S. J., Kheterpal, S., O'Reilly, M., Campbell, D. A.

“…The severity of illness in transplant patients and the complexity of transplant operations results in significant postoperative morbidity and mortality…”
Get full text

Who Pays for Biliary Complications Following Liver Transplant? A Business Case for Quality Improvement by Englesbe, M. J., Dimick, J., Mathur, A., Ads, Y., Welling, T. H., Pelletier, S. J., Heidt, D. G., Magee, J. C., Sung, R. S., Punch, J. D., Hanto, D. W., Campbell, D. A.

“…We use biliary complication following liver transplantation to quantify the financial implications of surgical complications and make a case for surgical…”
Get full text

Depression and Frailty in Patients With End‐Stage Liver Disease Referred for Transplant Evaluation by Cron, D. C., Friedman, J. F., Winder, G. S., Thelen, A. E., Derck, J. E., Fakhoury, J. W., Gerebics, A. D., Englesbe, M. J., Sonnenday, C. J.

“…End‐stage liver disease (ESLD) patients are believed to have a high prevalence of depression, although mental health in ESLD has not been studied…”
Get full text

Financial Implications of Pancreas Transplant Complications: A Business Case for Quality Improvement by Cohn, J. A., Englesbe, M. J., Ads, Y. M., Paruch, J. L., Pelletier, S. J., Welling, T. H., Sonnenday, C. J., Magee, J. C., Punch, J. D., Campbell, D. A., Sung, R. S.

“…We quantified the financial implications of surgical complications following pancreas transplantation. We reviewed medical and financial records of 49 pancreas…”
Get full text

Should heart, lung, and liver transplant recipients receive immunosuppression induction for kidney transplantation? by Ranney, D.N., Englesbe, M.J., Muhammad, W., Al-Holou, S.N., Park, J.M., Pelletier, S.J., Punch, J.D., Lynch, R.J.

“…Ranney DN, Englesbe MJ, Muhammad W, Al‐Holou SN, Park JM, Pelletier SJ, Punch JD, Lynch RJ. Should heart, lung, and liver transplant recipients receive…”
Get full text

Preliminary Analysis of Early Outcomes of a Prospective, Randomized Trial of Complete Steroid Avoidance in Liver Transplantation by Pelletier, S.J., Vanderwall, K., Debroy, M.A., Englesbe, M.J., Sung, R.S., Magee, J.C., Fontana, R.J., Punch, J.D.

“…Steroids are a mainstay in liver transplantation for induction and maintenance immunosuppression but are associated with significant adverse effects. While…”
Get full text

PROviding Better ACcess To ORgans: A comprehensive overview of organ‐access initiatives from the ASTS PROACTOR Task Force by Hobeika, M. J., Miller, C. M., Pruett, T. L., Gifford, K. A., Locke, J. E., Cameron, A. M., Englesbe, M. J., Kuhr, C. S., Magliocca, J. F., McCune, K. R., Mekeel, K. L., Pelletier, S. J., Singer, A. L., Segev, D. L.

“…The American Society of Transplant Surgeons (ASTS) PROviding better Access To Organs (PROACTOR) Task Force was created to inform ongoing ASTS organ access…”
Get full text